News Daily News Making Sense of MI: EXCEL and SYNTAX Tackle Event Definitions Michael O'Riordan September 28, 2020
News Daily News Multivessel PCI Helps Most in STEMI Patients With Severe Nonculprit Lesions Todd Neale September 11, 2020
News Daily News Coronary CTA Should Be First When Assessing Stable CAD: Consensus Document Yael L. Maxwell September 10, 2020
News Conference News ESC 2020 In Long-term, Real-world Data, CABG Bests PCI for Diabetic Patients With MVD Yael L. Maxwell September 01, 2020
News Conference News ESC 2020 LoDoCo2: Colchicine Protective in Large RCT of Chronic Coronary Disease Caitlin E. Cox August 31, 2020
News Daily News ECMO in AMICS: Amid Few Prospective Trials, a Multicenter Registry Yields Insights Caitlin E. Cox August 18, 2020
News Daily News Analysis Supports Short DAPT Followed by P2Y12 Inhibitor Monotherapy After DES PCI L.A. McKeown August 10, 2020
News Daily News Missing EXCEL MI Data Published, Prompting New Questions and Promised Answers Michael O'Riordan August 07, 2020
News Daily News Simple MIRACLE2 Score Could Help Triage Out-of-Hospital Cardiac Arrest Shelley Wood August 05, 2020
News Daily News Polymer-Free DES Hold No Long-term Advantage: ISAR-TEST-5 Michael O'Riordan July 07, 2020
News Daily News Short DAPT Reduces Bleeding With No Increase in MACE: Meta-analysis Yael L. Maxwell June 30, 2020
News Conference News EuroPCR 2020 No Survival Benefit With Revascularization in Stable CAD, Meta-analysis Confirms Michael O'Riordan June 26, 2020
News Daily News Cardiac Intervention and Surgery RCTs: Room for Improvement? Todd Neale June 03, 2020
News Daily News New EXCEL Analysis Reignites Debate Over PCI for Left Main CAD Michael O'Riordan June 01, 2020
News Daily News FDA Extends Ticagrelor Indication to High-Risk CAD Primary Prevention Shelley Wood June 01, 2020
News Daily News P2Y12 Inhibitor Monotherapy Edges Out Aspirin for Secondary Prevention Yael L. Maxwell May 15, 2020
News Daily News FOURIER Surveys Reassure About Cognitive Safety of Evolocumab Todd Neale May 06, 2020
News Daily News Alirocumab ‘Modestly’ Cost-effective at Lower List Price: ODYSSEY OUTCOMES Michael O'Riordan May 04, 2020
News Daily News Clopidogrel Holds Advantage in Older NTSE ACS Patients: POPular AGE Published Michael O'Riordan April 27, 2020